Strumento inattivo

Altre lingue KaloBios Pharmaceuticals Inc Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

05/01	Lo sviluppatore del trattamento COVID-19, Humanigen, presenta istanza di fallimento ai sensi del Capitolo 11.	RE
03/01	Humanigen, Inc. ha presentato istanza di fallimento	CI

Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	12/04
Final DIP Financing Approved for Humanigen, Inc.	08/03
Motion for Asset Sale Approved for Humanigen, Inc.	17/02
Notice for Auction Cancellation Filed by Humanigen, Inc.	13/02
Bidding Procedure Approved for Humanigen, Inc.	25/01
News Highlights : Top Company News of the Day	05/01
19 treatment developer Humanigen files for Chapter 11 bankruptcy	05/01
Motion for Asset Sale Filed by Humanigen, Inc.	04/01
Humanigen, Inc. Filed for Bankruptcy	03/01
Interim DIP Financing Approved for Humanigen, Inc.	03/01
Xspray Pharma Names Chief Commercial Officer	15/09/23
Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer	14/09/23
North American Morning Briefing : PCE Inflation -2-	31/08/23
North American Morning Briefing : Nasdaq Futures -2-	24/08/23
CapitalGainesReport: OTC Bounce List (EPAZ, ABML, HGEN, RINO)	09/08/23
Humanigen, Inc.(OTCPK:HGEN) dropped from S&P TMI Index	28/07/23
Sector Update: Health Care Stocks Steady in Late Afternoon Trading	25/07/23
Sector Update: Health Care Stocks Steady Tuesday Afternoon	25/07/23
Sector Update: Health Care	25/07/23
Humanigen Issues 'Going Concern' Warning; Shares Hit 52-Week Low	25/07/23

Non ci sono risultati per questa ricerca